ACR Convergence 2026 has ended. This guide stays up as the record of who was there. See upcoming conferences
Shanghai Qilu Pharmaceutical Research and Development Center at ACR Convergence 2026
Nov 6–11, 2026 Orlando, FL ~15k attendees Website
Shanghai Qilu Pharmaceutical Research and Development Center brings 3 presentations to ACR Convergence 2026 in Orlando. Its program centres on preclinical drug candidates for autoimmune disease, including a BCMA and CD19 dual-targeting T cell engager, a VAV1 molecular glue degrader and an anti-IFNAR1-TACI fusion protein tested in lupus models.
| Organization | ACR Convergence 2026 Attendance |
|---|---|
SQ Shanghai Qilu Pharmaceutical Research and Development Center Shanghai, China | |
A pharmaceutical research and development organization. | Poster Sun Nov 8 10:30am–12:30pm Poster Mon Nov 9 10:30am–12:30pm |
Find decision makers at Shanghai Qilu Pharmaceutical Research and Development Center
Tell us what you sell and we’ll find the people at Shanghai Qilu Pharmaceutical Research and Development Center most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by the American College of Rheumatology (ACR). Organization details are derived from the ACR’s published program and exhibitor floor plan, and each organization’s own website. Submit a correction